• Aucun résultat trouvé

Medication list: Enhancing patients’ knowledge and adherence

N/A
N/A
Protected

Academic year: 2022

Partager "Medication list: Enhancing patients’ knowledge and adherence"

Copied!
4
0
0

Texte intégral

(1)

Vol 53:  february • féVrier 2007 Canadian Family PhysicianLe Médecin de famille canadien

233

Current Practice

Pratique courante

Medication list

Enhancing patients’ knowledge and adherence

Marie-Thérèse Lussier

MD MSc

Claude Richard

PhD

I

n  this  article,  we  discuss  part  of  the  patient  interview  that,  in  our  opinion,  can  be  improved  by  using  some  simple  communication  strategies.  We  are  talking  about  one  of  the  most  humdrum  parts  of  the  whole  encoun- ter, when physicians ask patients whether they take any  medication.  The  purpose  of  this  question  is  to  get  infor- mation to make a list of the drugs patients take.

The communication strategies we propose are aimed  at  taking  advantage  of  patients’  responses  to  improve  maintenance of their medication files and dissemination  of information about medications. We propose 2 strate- gies, 1 specifically for patients you know, and the other  for new patients.

Patients you know

Physicians  generally  have  files  on  patients  they  know  and  thus  have  a  great  deal  of  information  about  them,  including a list of their active medications. As Figure 1  shows,  we  suggest  that  at  every  follow-up  visit  physi- cians  reserve  some  time  specifically  to  review  medica- tion  lists  in  the  files  or  lists  given  to  patients  by  their  pharmacists.  After  expressing  the  intention  to  take  a  few moments to ensure the list of medications is correct,  physicians  should  read  aloud  the  name,  dosage,  and  reason  for  each  prescription.  The  goal  here  is  twofold: 

to check the accuracy of the data in the file and to rein- force prescription information. Repeating this process at  every  visit  indicates  to  patients  how  important  doctors  consider their medications are.

Even  though  physicians  know  these  patients,  they  should  not  assume  the  lists  they  have  are  complete. 

Between  visits,  patients  might  have  consulted  pharma- cists,  other  general  practitioners,  or  specialists.  They  might have visited walk-in clinics, emergency rooms, or  even  been  hospitalized.  If  they  have  done  any  of  these  things,  new  medications  might  have  been  prescribed  or  purchased  in  a  pharmacy  or  natural  food  store.  It  is  possible  that,  if  patients  consulted  other  physicians  or  pharmacists  for  reasons  they  think  bear  no  relation  to  their current visit, they might not report additional drugs  without  being  prompted.  For  example,  a  patient  might  be  taking  an  anti-inflammatory  medication  for  a  mus- culoskeletal  disorder  but  might  not  think  to  mention  it  to  a  doctor  being  consulted  about  hypertension.  It  is  essential  to  ask  patients  explicitly  whether  new  medi- cations  should  be  added  to  the  list  and  to  specify  the  reason  for  and  dosage  of  the  new  medications.  This  will  foster  patients’  participation  in  the  consultation. 

Such  involvement  on  patients’  part  could  help  ensure  their  success  in  managing  the  medications  at  home. 

Physicians  should  then  repeat  the  information  in  order  to  check  that  patients  have  understood  it  properly  and  to  reinforce  patients’  behaviour.  Again,  this  is  a  point  at which physicians can correct or clarify their patients’ 

knowledge of their medications.

Once  the  prescribed  medications  have  been  added  to  the  list,  physicians  must  ask  their  patients  explicitly  whether  they  take  over-the-counter,  particularly  “nat- ural,”  products.  Patients  might  have  decided  to  take  these on their own and might not necessarily think them  worth reporting. 

Throughout  the  information-gathering  process,  phy- sicians  must  try  to  foster  patients’  participation.  They  should  also  take  time  to  ask  whether  patients  are  hav- ing  any  problems  with  their  drug  regimens.  If  they  are,  physicians should work with them to try to find concrete  solutions  adapted  to  their  particular  circumstances.  At  this point in the interview, physicians should also inquire  explicitly whether their patients have noticed any adverse  effects that they associate with the medications. 

At  the  end  of  the  interview,  physicians  can  provide  patients with a corrected list of prescribed and over-the- counter drugs that includes the name, dosage, and rea- son  for  taking  each  medication.  Physicians  should  tell  patients to keep the reminder list in a convenient place  at  home  and  to  give  copies  to  their  pharmacists.  This  ensures  good  circulation  of  information  between  main  care  providers.  Physicians  should  also  remind  patients  how important it is to bring the list along to every medi- cal consultation.

New patients

In the case of new patients, physicians generally do not  have a list of medications and have to draw one up. First,  simply ask new patients an open question: “Do you cur- rently  take  any  medications  under  prescription  or  that  have  been  prescribed  to  you?”  We  suggest  you  spec- ify  drugs  “under  prescription”  or  “that  have  been  pre- scribed”  to  help  patients  organize  the  information  they  give  you.  This  strategy  allows  you  to  ask  patients  spe- cifically  whether  they  are  taking  over-the-counter  prod- ucts. If they take no prescribed drugs, you can ask about  over-the-counter  medications  right  at  the  beginning  of  the  interview  (Figure 2).  If  they  do  take  prescribed  drugs, you can ask a little later when you complete the  list of prescribed drugs.

Communication Tips

(2)

234

Canadian Family PhysicianLe Médecin de famille canadien Vol 53:  february • féVrier 2007

Communication Tips

Figure 1. Maintaining the medication profile of patients you know

Check medication list at beginning of interview

Physicians should repeat Name

Dosage Reason for all drugs listed

Reinforces checks

Visits to other doctors or

hospitalizations Are there any new prescription drugs?

YES NO

YES NO

Are there new nonprescription drugs?

Can you name them for me?

Fosters patients’ participation Evaluate adherence Repeat

Name Dosage Reason

Reinforces Verifies

Normalization Open questions or problems Discuss solutions Check for adverse effects

Continue the interview Add to medication list

Fosters patients’ participation Interview ends.

Give photocopy of corrected list to patient

with instructions to keep it

(3)

Vol 53:  february • féVrier 2007 Canadian Family PhysicianLe Médecin de famille canadien

235

Communication Tips

Figure 2. Maintaining the medication profile of new patients

Are you currently taking any drugs under prescription?

Open question

YES

YES

YES

YES

NO

NO

NO

NO

Can you name them for me? Are you currently taking any nonprescription drugs?

Continue interview Patient names drugs

Obtain details from patient:

dosage and reasons

Evaluate adherence and adverse effects Doctor names drug and

enters it into file

Repeats verifies

Verifies

Normalization Open questions or problems Discuss solutions

Are there any others whose names you forget?

Obtain permission to telephone pharmacy or ask patient to bring to next appointment Give patient name of drug and ensure he or she knows dosage and reason for prescription

Give drug list to patient

Fosters participation

(4)

236

Canadian Family PhysicianLe Médecin de famille canadien Vol 53:  february • féVrier 2007

Communication Tips

The  rest  of  the  encounter  should  proceed  as  sug- gested  for  established  patients  except  that  you  must  make sure you cover all medications taken, even those  whose  names  patients  cannot  remember.  Depending  on the urgency of finding out the names of the drugs, 2  strategies are possible. Either ask patients’ permission to  contact their pharmacists directly or agree that they will  bring  all  their  medications  with  them  to  the  next  visit. 

When  you  have  the  names  of  the  medications,  repeat  them aloud and make sure patients know what the dos- age is and why they are taking each drug. You may then  go on to evaluate adherence and adverse effects as you  would for established patients.

Give your patients the list you have made up of their  medications,  dosages,  and  reasons  the  drugs  are  being  taken.  Tell  them,  as  you  would  patients  you  know,  to  keep  the  reminder  list,  bring  it  to  every  one  of  their  medical consultations, and give a copy to their pharma- cists. This will give them a very clear message that you  attach great importance to the medications they take.

Conclusion

Drawing  up  a  complete  list  of  the  drugs  patients  take  requires the cooperation of patients and pharmacists and  a few minutes of the medical interview, which should be  planned ahead of time. Drawing up the list the first time  for patients you know or for new patients should be part  of your time allocation.

During subsequent visits, checking the medication list  should  take  less  time.  The  approach  suggested  here  is  original in that it incorporates a practical way of verify- ing adherence and inquiring about adverse drug effects,  2  often  neglected  aspects  of  medication  use,  both  of  which  are  extremely  important  for  appropriate  health  management. 

Dr Richard is a psychologist and Dr Lussier is a family physician in Montreal, Que.

acknowledgment

This article in the series “Communication Tips” has been adapted from an article that originally appeared in the French- language journal L’Omnipracticien. We thank Merck Frosst Canada for covering the costs of adaptation and translation.

✶ ✶ ✶

Références

Documents relatifs

Determinants of the management in LBP: duration of epidose, intensity of pain and radiating pain. (Kovacs BMC HSR 2006 / Webster J Gen Intern

22.2% of patients partially compliant and 25.9% noncompliant Variables linked to noncompliance: education level; complications related to hypertension; side-effects;

Although the concept of reference centres and networks is known in most European health care systems, a review of experiences in 20 EU Member States and Norway found substantial

3.My sister(not – to like ) doesn’t like making posters but she (like)likes talking to students.. My sister doesn’t like making posters but she likes talking

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des

Factors associated with adherence to medication according to linear regression models using MARS a total score, BIS-10 b nonplanning impulsivity sub-scale score, age, illness

The Canadian Pharmacogenomics Network for Drug Safety (CPNDS), 3 a group focused on incorporating pharmacogenomics into clinical practice, has identi- fied genomic

Patients know the risks of unhealthy behaviours and try to change it by being active. Adapted care